FDA approves Ironwood's gout combination drug

07:43 EDT 22 Aug 2017 | pharmaphorum

The FDA has approved Ironwood Pharmaceuticals’ gout drug, Duzallo, although the regulator has required a black box warning highlighting risk of kidney failure. A once-daily drug, Duzallo combines the standard of care treatment, allopurinol, with...

Original Article: FDA approves Ironwood's gout combination drug


More From BioPortfolio on "FDA approves Ironwood's gout combination drug"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...